MiRXES is a Singaporean biotech company that’s listed on the Hong Kong stock exchange. Today Elaine Boey will be sitting down with co-founder and CEO, Dr. Zhou Lihan to talk about the technology that the company employs, challenges as Southeast Asia’s biotech unicorn, when it might turn profitable, and whether you should be a shareholder.
Image Credit: Shutterstock.com

IKEA: Balancing Affordability, Sustainability & Growth
21:10

UCSI University: Competition in the Higher Education Space
22:50

Can ASEAN’s Digital Needs Push EdgePoint Past Key Pressures?
23:32